최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Autoimmunity reviews, v.16 no.1, 2017년, pp.96 - 101
Esposito, S. , Longo, M.R.
The term Guillain-Barre syndrome (GBS), the most frequent cause of acute paralytic neuropathy, covers a number of recognisably distinct variants. The exact cause of GBS is unknown, but 50-70% of cases appear 1-2weeks after a respiratory or gastrointestinal infection, or another immune stimulus that ...
Neuroepidemiology Sejvar 36 123 2011 10.1159/000324710 Population incidence of Guillain-Barre syndrome: a systematic review and meta-analysis
N Engl J Med Ropper 17 1130 1992 The Guillain-Barre symptom complex
Eur J Pediatr Schessl 165 605 2006 10.1007/s00431-006-0140-1 Infections and vaccinations preceding childhood Guillain-Barre symptom complex: a prospective study
Curr Opin Neurol Ho 12 389 1999 10.1097/00019052-199908000-00004 Guillain-Barre syndrome
Ann Neurol Alter 27 S7 1990 10.1002/ana.410270704 The epidemiology of Guillain-Barre syndrome
Lancet Willison 388 717 2016 10.1016/S0140-6736(16)00339-1 Guillain-Barre syndrome
Neurology Walgaard 76 968 2011 10.1212/WNL.0b013e3182104407 Early recognition of poor prognosis in Guillain-Barre syndrome
Arch Neurol Hughes 62 1194 2005 10.1001/archneur.62.8.1194 Supportive care for patients with Guillain-Barre syndrome
Q J Med Winner 77 1297 1990 10.1093/qjmed/77.3.1297 Age-specific incidence of Guillain-Barre syndrome in Oxfordshire
Acta Neurol Scand Halls 78 118 1998 10.1111/j.1600-0404.1988.tb03632.x Guillain-Barre syndrome; diagnostic criteria, epidemiology, clinical course and prognosis
Pediatr Rev Beth 33 164 2012 10.1542/pir.33-4-164 Guillain-Barre syndrome
Lancet Hughes 366 1653 2005 10.1016/S0140-6736(05)67665-9 Guillain-Barre syndrome
Neurology van Koningsveld 54 620 2000 10.1212/WNL.54.3.620 Mild forms of Guillain-Barre syndrome in an epidemiologic survey in The Netherlands
Acta Neurol Scand Bogliun 110 100 2004 10.1111/j.1600-0404.2004.00272.x Incidence and clinical features of acute inflammatory polyradiculoneuropathy in Lombardy, Italy
Expert Rev Clin Immunol Jasti 1 2016 Guillain-Barre syndrome: causes, immunopathogenic mechanisms and treatment
J Neuroimmunol Loshaj-Shala 289 168 2015 10.1016/j.jneuroim.2015.11.005 Guillain Barre syndrome (GBS): new insights in the molecular mimicry between C. jejuni and human peripheral nerve (HPN) proteins
Clin Infect Dis Orlikowski 52 837 2011 10.1093/cid/cir074 Guillain-Barre syndrome following primary cytomegalovirus infection: a prospective cohort study
Handb Clin Neurol Tselis 123 285 2014 10.1016/B978-0-444-53488-0.00013-4 Epstein-Barr virus infections of the nervous system
Emerg Infect Dis Hawken 21 224 2015 10.3201/eid2102.131879 Simulation study of the effect of influenza and influenza vaccination on risk of acquiring Guillain-Barre syndrome
Eur J Epidemiol Ghaderi 31 67 2016 10.1007/s10654-015-0047-0 Risk of Guillain-Barre syndrome after exposure to pandemic influenza a(H1N1)pdm09 vaccination or infection: a Norwegian population-based cohort study
Ann Neurol Meyer Sauteur 2016 10.1002/ana.24755 Mycoplasma pneumoniae triggering the Guillain-Barre syndrome: a case-control study
Euro Surveill Williams 2016 21 2016 Cluster of atypical adult Guillain-Barre syndrome temporally associated with neurological illness due to EV-D68 in children, South Wales, United Kingdom, October 2015 to January 2016
Lancet Cao-Lormeau 387 1531 2016 10.1016/S0140-6736(16)00562-6 Guillain-Barre syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study
N Engl J Med Broutet 374 1506 2016 10.1056/NEJMp1602708 Zika virus as a cause of neurologic disorders
Autoimmun Rev Lucchese 15 801 2016 10.1016/j.autrev.2016.03.020 Zika virus and autoimmunity: from microcephaly to Guillain-Barre syndrome, and beyond
Autoimmun Rev Lucchese 15 854 2016 10.1016/j.autrev.2016.04.003 Reply concerning the article "Zika virus and autoimmunity: from microcephaly to Guillain-Barre syndrome, and beyond"
J Neurol Neurosurg Psychiatry Gadre 81 812 2010 10.1136/jnnp.2009.185504 Rabies viral encephalitis: clinical determinants in diagnosis with special reference to paralytic form
Vaccine Martin Arias 33 3773 2015 10.1016/j.vaccine.2015.05.013 Guillain-Barre syndrome and influenza vaccines: a meta-analysis
Vaccine Bardenheier 34 4406 2016 10.1016/j.vaccine.2016.07.019 Adverse events following pandemic influenza a (H1N1) 2009 monovalent and seasonal influenza vaccinations during the 2009-2010 season in the active component U.S. military and civilians aged 17-44years reported to the Vaccine Adverse Event Reporting System
Drug Saf Haber 32 309 2009 10.2165/00002018-200932040-00005 Vaccines and Guillain-Barre syndrome
ILAR J Soliven 54 282 2014 10.1093/ilar/ilt054 Animal models of autoimmune neuropathy
Int Immunopharmacol. Sudo 40 11 2016 10.1016/j.intimp.2016.08.019 Polyclonal IgM and IgA block in vitro complement deposition mediated by anti-ganglioside antibodies in autoimmune neuropathies
Drugs Kuwabara 64 597 2004 10.2165/00003495-200464060-00003 Guillain-Barre syndrome. Epidemiology, pathophysiology and management
J Clin Neuromuscul Dis DiCapua 17 47 2015 10.1097/CND.0000000000000091 Relationship between cerebrospinal fluid protein levels and electrophysiologic abnormalities in Guillain-Barre syndrome
Expert Rev Vaccines Moise 15 607 2016 10.1586/14760584.2016.1123098 T cell epitope redundancy: cross-conservation of the TCR face between pathogens and self and its implications for vaccines and autoimmunity
Bull Mem Soc Med Hop Paris Guillain 28 1462 1916 Sur un syndrome de radiculo-nevrite avec hyperalbuminose du liquide cephalorachidien sans reaction cellulaire. Remarques sur les caracteres cliniques et graphiques desrefl exes tendineux
Autoimmun Rev Eldar 13 525 2014 10.1016/j.autrev.2014.01.033 Guillain Barre syndrome and other immune mediated neuropathies: diagnosis and classification
Pediatrics Korinthenberg 116 8 2005 10.1542/peds.2004-1324 Intravenously administered immunoglobulin in the treatment of childhood Guillain-Barre syndrome: a randomized trial
Cochrane Database Syst Rev Hughes 9 2014 10.1002/14651858.CD002063.pub6 Intravenous immunoglobulin for Guillain-Barre syndrome
Pharmacol Rep Anand 62 220 2010 10.1016/S1734-1140(10)70261-9 Guillain-Barre syndrome
Lancet Hahn 352 635 1998 10.1016/S0140-6736(97)12308-X Guillain-Barre syndrome
Neurology van den Berg 82 1984 2014 10.1212/WNL.0000000000000481 Paraparetic Guillain-Barre syndrome
J Neurol Yuki 259 1181 2012 10.1007/s00415-011-6330-4 Guillain-Barre syndrome associated with normal or exaggerated tendon reflexes
Brain Fokke 137 Pt 1 33 2014 10.1093/brain/awt285 Diagnosis of Guillain-Barre syndrome and validation of Brighton criteria
Lancet Neurol van Doorn 7 939 2008 10.1016/S1474-4422(08)70215-1 Clinical features, pathogenesis, and treatment of Guillain-Barre syndrome
Ann Neurol McKhann 33 333 1993 10.1002/ana.410330402 Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China
Ann Neurol Griffin 39 17 1996 10.1002/ana.410390105 Pathology of the motor-sensory axonal Guillain-Barre syndrome
Nat Rev Neurol van den Berg 10 469 2014 10.1038/nrneurol.2014.121 Guillain-Barre syndrome: pathogenesis, diagnosis, treatment and prognosis
Neurology Roodbol 76 807 2011 10.1212/WNL.0b013e31820e7b62 Recognizing Guillain-Barre syndrome in preschool children
Br Med J Al-Din 291 535 1985 10.1136/bmj.291.6494.535 Coma and brain stem areflexia in brain stem encephalitis (Fisher's syndrome)
J Peripher Nerv Syst Roodbol 19 121 2014 10.1111/jns5.12068 Long-term outcome of Guillain-Barre syndrome in children
Brain Hughes 130 2245 2007 10.1093/brain/awm004 Immunotherapy for Guillain-Barre syndrome: a systematic review
Acta Neurol Scand ivkovi 2015 Intravenous immunoglobulin in the treatment of neurologic disorders
J Peripher Nerv Syst Darweesh 19 24 2014 10.1111/jns5.12051 Health-related quality of life in Guillain-Barre syndrome patients: a systematic review
Curr Opin Pediatr Ryan 25 689 2013 10.1097/MOP.0b013e328365ad3f Pediatric Guillain-Barre syndrome
J Peripher Nerv Syst Wong 20 47 2015 10.1111/jns.12104 Cytoalbuminologic dissociation in Asian patients with Guillain-Barre and Miller Fisher syndromes
Arch Dis Child Educ Pract Ed Agrawal 92 161 2007 10.1136/adc.2004.065706 Management of children with Guillain-Barre syndrome
Ann Neurol Walgaard 67 781 2010 Prediction of respiratory insufficiency in Guillain-Barre syndrome
Brain Ho 118 597 1995 10.1093/brain/118.3.597 Guillain-Barre syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies
Childs Nerv Syst Yikilmaz 26 1103 2010 10.1007/s00381-010-1197-8 Magnetic resonance imaging of childhood Guillain-Barre syndrome
Am J Neuroradiol Zuccoli 32 639 2011 10.3174/ajnr.A2358 Redefining the Guillain-Barre spectrum in children: neuroimaging findings of cranial nerve involvement
Trends Immunol Willison 34 453 2013 10.1016/j.it.2013.05.001 Glycolipid antigens and autoantibodies in autoimmune neuropathies
Cochrane Database Syst Rev Liu 4 2015 10.1002/14651858.CD009950.pub3 Pharmacological treatment for pain in Guillain-Barre syndrome
Neurology Ruts 75 1439 2010 10.1212/WNL.0b013e3181f88345 Pain in Guillain-Barre syndrome: a long-term follow-up study
Hum Vaccin Immunother Vitaliti 11 2749 2015 10.1080/21645515.2015.1061161 The usefulness of immunotherapy in pediatric neurodegenerative disorders: a systematic review of literature data
Pharmacol Rep Pithadia 62 220 2010 10.1016/S1734-1140(10)70261-9 Guillain-Barre syndrome
Eur Neurol Schaller 46 167 2001 10.1159/000050798 Successful treatment of Guillain-Barre syndrome with combined administration of interferon-beta-1 and intravenous immunoglobulin
Bone Marrow Transplant Ostronoff 42 71 2008 10.1038/bmt.2008.81 Rituximab-responsive Guillain-Barre syndrome following allogeneic hematopoietic SCT
※ AI-Helper는 부적절한 답변을 할 수 있습니다.